Screens and assessments are used for a variety of reasons (detection, monitoring, outcomes, etc.). However the requirement is always the same. How to measure a latent trait accurately, using questions and logic. The actual cost of a screening measure has little to do with whether it is public domain or licensed. The depth and accuracy of information and how well it supports treatment, or qualified hand offs and referrals, is the real value.
Many studies have shown that the sooner you address developmental delays, autism spectrum and social emotional issues, the more effective the treatment, the better the outcome and lower the costs. While there are alternatives like the or , typically the ASQ-3 is used for developmental screening, the M-CHAT-2 for autism screening and the ASQ:SE-2 for social emotional screening.
In-depth assessments such as the QPD, BHI-2, BBHI-2, etc. can cover as many as 10 or 20 different latent traits. They offer a broader picture of the psychological condition of the patient, saving the provider a significant amount of time not having to gather the information themselves. These types of assessments work well in Specialty settings where in-depth information is necessary and patients have the time to complete the assessments.
In IBH settings the idea is to universally detect, and probe deeper when indicated. Detection can be simple depression or maybe a combination of depression (PHQ-9), anxiety (GAD-7), alcohol (AUDIT-10) and substance abuse (DAST-10), all indicators of psychological distress. Probing deeper may include more measures like ( ) and Mania ( ), or doing a comprehensive assessment like the QPD. Using screening and assessment measures to probe deeper is a cost-effective way to make higher quality hand offs. It also gets both the medical and behavioral health staff up to speed faster.
Depression screening is the psychological equivalent to taking a patient’s temperature. It works well as an indicator of psychological distress, but you need to probe further to see what is the underlying problem(s). There are a host of depression measures ( , , , etc.) but the de facto standard measure in medical settings is the PHQ-9.
Anxiety is generally around 70% co-morbid with depression. It is important in medical setting because it often manifests itself as medical symptoms. The is an alternative but the de facto standard measure in medical settings is the GAD-7.
You need to detect and potentially treat alcohol and substance abuse. However, alcohol and substance abuse are often co-morbid with psychological distress due to the patient self-medicating. There are a range of alcohol and substance abuse measures being used, AUDIT-10, DAST-10, , to name a few.
Having established psychological distress and some of it’s symptoms you can probe into underlying causes. can be a root cause locking in the psychological distress and making the patient resistant to treatment. The and the are often used but an in-depth assessment like the QPD may be a better choice.
If you are considering prescribing anti-depressants, you want to be certain the patient is not bi-polar. You can screen for mania using an abridged , but similar to , an in-depth assessment like the QPD is probably a better choice.